98%
921
2 minutes
20
Adult-onset leukodystrophies though individually rare are not uncommon. This group includes several disorders with isolated adult presentations, as well as several childhood leukodystrophies with attenuated phenotypes that present at a later age. Misdiagnoses often occur due to the clinical and radiological overlap with common acquired disorders such as infectious, immune, inflammatory, vascular, metabolic, and toxic etiologies. Increased prevalence of non-specific white matter changes in adult population poses challenges during diagnostic considerations. Clinico-radiological spectrum and molecular landscape of adult-onset leukodystrophies have not been completely elucidated at this time. Diagnostic approach is less well-standardized when compared to the childhood counterpart. Absence of family history and reduced penetrance in certain disorders frequently create a dilemma. Comprehensive evaluation and molecular confirmation when available helps in prognostication, early initiation of treatment in certain disorders, enrollment in clinical trials, and provides valuable information for the family for reproductive counseling. In this review article, we aimed to formulate an approach to adult-onset leukodystrophies that will be useful in routine practice, discuss common adult-onset leukodystrophies with usual and unusual presentations, neuroimaging findings, recent advances in treatment, acquired mimics, and provide an algorithm for comprehensive clinical, radiological, and genetic evaluation that will facilitate early diagnosis and consider active treatment options when available. A high index of suspicion, awareness of the clinico-radiological presentations, and comprehensive genetic evaluation are paramount because treatment options are available for several disorders when diagnosed early in the disease course.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410460 | PMC |
http://dx.doi.org/10.3389/fneur.2023.1219324 | DOI Listing |
AJNR Am J Neuroradiol
August 2025
From the Neuroradiology Unit, Department of Diagnostic and Interventional Radiology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy (F.C., G.M.); Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK (S.P., F.D'A., U.L., P.G., P.V., K
Background And Purpose: GM1 gangliosidosis is a rare lysosomal storage disorder caused by pathogenic variants in the gene, leading to deficient β-galactosidase activity and accumulation of gangliosides. This multi-institutional retrospective study aims to systematically characterize neuroimaging features across all clinical subtypes of GM1 gangliosidosis.
Materials And Methods: Patients were retrospectively identified from 4 centers based on confirmed variants or βgalactosidase deficiency.
Neurogenetics
August 2025
Unit of Rare Neurological Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, via Celoria 11, 20133, Milano, Italia.
A 40-year-old man with adult-onset spastic-ataxia and tremor showed a leukoencephalopathy with a hypomyelinating pattern on brain MRI. Whole-exome sequencing identified two novel likely pathogenic variants in KIF1C, a gene associated with spastic-ataxia type 2 (SPAX2). This case supports including KIF1C among the causes of adult-onset hypomyelinating leukodystrophies and highlights the diagnostic overlap between spastic-ataxia, hereditary spastic paraplegia, and hypomyelinating leukodystrophies, underscoring the limitations of current nomenclature.
View Article and Find Full Text PDFJ Inherit Metab Dis
September 2025
Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands.
Patients with metachromatic leukodystrophy (MLD) show variable motor and cognitive decline. The ARSA variants c.256C>T, p.
View Article and Find Full Text PDFMov Disord
July 2025
INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau, ICM, Paris, France.
Background: Colony stimulating factor-1 receptor (CSF1R)-related disorder (CSF1R-RD) is an autosomal dominant, rapidly progressive, demyelinating disease leading to death usually within a few years. Because of the central role of CSF1R in microglia functions, allogeneic hematopoietic stem cell transplantation (HSCT) has been suggested as a therapy for CSF1R-RD.
Objectives: To report multicenter clinical (Expanded Disability Scoring Scale [EDSS]), neurocognitive), neuroimaging (Sundal score), and biological (neurofilament light chain [NfL]) outcomes after HSCT in CSF1R-RD.
Cureus
June 2025
Department of Neurology, University of Florida College of Medicine, Gainesville, USA.
Alexander disease (AxD) is a rare leukodystrophy caused by heterozygous mutations in . We report the case of a 67-year-old woman with progressive dysarthria, dysphagia, ataxia, and oculomotor dysfunction. MRI revealed medullary and cervical spinal cord atrophy with a periventricular T2/fluid-attenuated inversion recovery (FLAIR) hyperintense rim, findings characteristic of adult-onset AxD.
View Article and Find Full Text PDF